Regeneron to retrofit Dell's Ireland facility for manufacturing drugs
Biopharmaceutical company Regeneron Pharmaceuticals is set to retrofit a former Dell 400,000 ft2 computer site in Limerick, Ireland as its second manufacturing facility.
Regeneron corporate communications vice president Peter Dworkin was quoted by FiercePharmaManufacturing as saying, "It will become a second manufacturing site, after our site in Rensselaer.
"Ireland is part of the EU so obviously it gives us the opportunity to more closely supply our partners from Europe," Dworkin added.
The acquisition is subject to approvals from local authorities, while products to be manufactured remain undecided.
In quarterly financial filing 2013, the company said, "We intend to renovate this facility to accommodate and support our growth, primarily in connection with expanding our manufacturing capacity to support our global supply chain."
According to SEC filing, the company expects to invest nearly $250m to $300m on capital projects through 2014, which also includes facility acquisition and retrofit work.
Drug Research Drug Delivery Drug Discovery & Development
Contract Research & Services Clinical Trials Contract Research Contract Services
Automation IT & Software Laboratory Instrumentation
Inward Investment Packaging Regulatory Affairs
This report is a crucial resource for industry executives and anyone looking to access key information about "Shire Plc" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report. Buy online from $250